Regeneron Pharmaceuticals (NASDAQ:REGN): Q1 EPS of $1.78 beats by $0.37. Revenue of $440M beats by $15.74M. (PR)
Regeneron Pharmaceuticals (NASDAQ:REGN): Q1 EPS of $1.78 beats by $0.37. Revenue of $440M beats...
Recommended For You
More Trending News
About REGN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
REGN | - | - |
Regeneron Pharmaceuticals, Inc. |